PD-L1 positivity in the whole tumor was detected in 43% (40/93) of our cases upon visual microscopic review, including 27% (11/41) of WHO grade I, 47% (23/43) of WHO grade II, and 67% (6/9) of WHO grade III tumors. This evidence concerns the gene CD274 and neoplasm.